
Bepridil - Wikipedia
Bepridil (trade name Vascor) is an diamine calcium channel blocker once used to treat angina pectoris. It is no longer sold in the United States. It is nonselective. [1] It has been discussed …
Bepridil: Uses, Interactions, Mechanism of Action - DrugBank Online
Bepridil is a calcium channel blocker that has well characterized anti-anginal properties and known but poorly characterized type 1 anti-arrhythmic and anti-hypertensive properties. It is …
bepridil (Vascor): Angina Drug Uses, Side Effects & Dosage - MedicineNet
Bepridil is prescribed for patients with angina pectoris (heart pain) due to coronary artery disease. Vascor (bepridil hydrochloride) is indicated for the treatment of chronic stable angina (classic …
Bepridil | C24H34N2O | CID 2351 - PubChem
Bepridil is a tertiary amine in which the substituents on nitrogen are benzyl, phenyl and 3-(2-methylpropoxy)-2-(pyrrolidin-1-yl)propyl. It has a role as a vasodilator agent, an anti …
Vascor (Bepridil): Side Effects, Uses, Dosage, Interactions ... - RxList
Aug 15, 2022 · VASCOR (bepridil hydrochloride) is a calcium channel blocker that has well characterized anti-anginal properties and known but poorly characterized type 1 anti …
Bepridil Side Effects: Common, Severe, Long Term - Drugs.com
Bepridil has generally been well-tolerated. Although adverse side effects have been reported in up to 87% of patients, most were mild to moderate in severity. [Ref] Cardiovascular side effects …
Bepridil. A review of its pharmacological properties and …
Bepridil is a calcium antagonist with direct negative chronotropic, dromotropic, inotropic and vasodilatory actions which reduces myocardial oxygen consumption and increases coronary …
Pharmacology of bepridil - American Journal of Cardiology
Apr 9, 1992 · Bepridil is an antianginal agent with multiple therapeutic actions. It decreases calcium influx through potential-dependent and receptor-operated sarcolemmic calcium …
BEPRIDIL HYDROCHLORIDE - National Center for Advancing …
Bepridil is a calcium channel blocker that has well characterized anti-anginal properties and known but poorly characterized type 1 anti-arrhythmic and anti-hypertensive properties.
Bepridil: a review of its pharmacology and clinical efficacy
Bepridil is an anti-anginal agent with a novel chemical structure. Its main pharmacological effects are an increase in coronary blood flow, a reduction in myocardial oxygen demand, reduction in …